Évaluation du traitement symptomatîque des poussées de surinfection de BPCO : Étude préliminaire Pneumorel 80 mg versus placebo en association avec une antibiothérapie

Revue de Pneumologie Clinique

Volumn 56, Issue 1, 2000, Pages 17-24

  Lirsac, B ^a,c   Benezet, O ^a,c   Dansin, E ^b   Nouvet, G ^c   Stach, B ^d   Voisin, C ^e  

^a Centre de Pneumologie   (France)

^b Nîmes   (France)

^c Hôpital C Nicolle ^*  (France)

^d HÔPITAL CHARLES NICOLLE   (France)

^e Clinique Tessier   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; FENSPIRIDE; PLACEBO;

ADULT; AGED; ANTIBIOTIC THERAPY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHENIA; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG INDUCED DISEASE; EPILEPSY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTENSION; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; BRONCHITIS; BRONCHODILATOR AGENTS; COMBINED MODALITY THERAPY; CYCLOOXYGENASE INHIBITORS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SPIRO COMPOUNDS; TREATMENT OUTCOME;

EID: 0034045043     PISSN: 07618417     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Société de Pneumologie de Langue Française. Recommandations pour la prise en charge des bronchopneumopathies chroniques obstructives. Rev. Mal. Respir., 1997, 14, 225-32.
2. Grossman R. F. : Guidelines for the treatment of acute exacerbations of chronic bronchitis. Chest, 1997, 112 (6 SuppL), 310S-313S.
3. Cosentino A. M. : Out-patient management of asthma & COPD. Compr. Then, 1997, 23, 67-72.
4. Cazzola M., Matera M. G., Rossi F. : Bronchial hyperresponsiveness and bacterial respiratory infections. Clin. Ther., 1991, 13, 157-71.
5. Jorgensen A. F, Coolidge J., Pedersen P. A., Petersen K. P., Waldorff S., Widding E. : Amoxicillin in treatment of acute uncomplicated exacerbations of chronic bronchitis. A doubleblind, placebo-controlled multicentre study in general practice. Scand. J. Prim. Health Care, 1992, 10, 7-11.
6. Aboussouan L. S. : Acute exacerbations of chronic bronchitis : focusing management for optimum results. Postgrad. Mcd. J., 1996, 99, 89-90, 95-8, 101-2.
7. Fagon J. Y., Chastre J. : Severe exacerbations of COPD patients : the role of pulmonary infections. Semin. Respir. Infect., 1996,11, 109-18.
8. Anthonisen N. R., Manfreda J., Warren C. P. \V., Hershfield E. S., Harding G. K. M., Nelson N. A. : Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann. intern. Med., 1987, 706, 196-204.
9. O'Brien C., Leung B., Hill S. L., Campbell E. J., Stockley R.A. : The nature of exacerbations of chronic obstructive pulmonary disease (COPD). Eur. Respir. J., 1998, 12, 16S : 2S7-2S91.
10. Evrard Y., Kalo G., Bodinier M. D., Chapelain B. : Fenspiride and inflammation in experimental pharmacology. Eur. Respir. Rev., 1991, I, 33-40.
11. Pipy B., Evrard Y. : Inflammation expérimentale et effets du fenspiride sur les cytokines, les metabolites de l'acide arachidonique et la migration cellulaire. Lettre du Pharmacologue, 1992, 6, 13-9.
12. Barbera J. A., Roca J., Ferrer A., et al. : Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease. Eiir. Respir. J., 1997, JO, 1285-91.
13. Rahman I., Morrison D., Donaldson K., MacNee W. : Systemic oxidative stress in asthma, COPD, and smokers. Am. J. Respir. Crit. Care Med., 1996, 154, 1055-60.
14. Fraisse A., Mallet C. : Intérêt thérapeutique du fenspiride injectable au cours des poussées de surinfection chronique aiguë de l'adulte et du vieillard. Gazette Médicale de France, 1978, 85, 2435-6.
15. Reboul R., Mallet C. : Intérêt de Pneumorel injectable et de Pneumorel retard dans le traitement des poussées de surinfections saisonnières des bronchopneumopathies de l'adulte. Vie Médicale, 1978,59, 2107-10.
16. Taranger P., Dumon J. F. : Etude de l'activité et de l'acceptabilité thérapeutique du fenspiride injectable dans les surinfections aiguës des bronchopneumopathies de l'adulte. Sciences Médicales, 1978, 6, 42-8.
17. Akoun G., et al. : Effects of fenspiride on airway respiratory function and blood gases in stable COPD patients. Enr. Resp. Rev., 1991, /, (French version) : 51-65.